NCT06816823View on ClinicalTrials.gov

CAR-NK Cells (CL-NK-001) in Pancreatic Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 7, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

CL-NK-001

Dose level 1 (5 × 10\^8 cells); dose level 2 (15 × 10\^8 cells); dose level 3 (30 × 10\^8 cells); additional dose levels (investigator's discretion).

Trial Locations (1)

200433

RECRUITING

Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER